Submission package RETRO-VASCULAID-AAA clinical DATA study
(odnośnik otworzy się w nowym oknie)
Submission package RETRO-VASCULAID-AAA clinical DATA study (ethical approval, final study protocol, registry nr) prior to first enrolment.RETRO-VASCULAID-AAA clinical DATA study: retrospective data collection of 5000 patients at clinical partners (Annex Clinical Studies).
Protocol and SOPs for collection of data for each data type
(odnośnik otworzy się w nowym oknie)
Protocol and SOPs for collection of data (medical images and pathological analysis) for each data type
A functional design describing the architecture and data flows that will be forming the apps
(odnośnik otworzy się w nowym oknie)
A functional design describing the architectureand data flows that will be forming the apps will be delivered.
Submission package PRO-VASCULAID-AAA clinical DATA study
(odnośnik otworzy się w nowym oknie)
Submission package PRO-VASCULAID-AAA clinical DATA study (ethical approval, final study protocol, registry nr, national authorities) prior to first enrolment.PRO-VASCULAID-AAA clinical DATA study: prospective data collection of 350 patients (phase I) at clinical partners (Annex Clinical Studies).
Submission package RETRO-VASCULAID-PAD clinical DATA study
(odnośnik otworzy się w nowym oknie)
Submission package RETRO-VASCULAID-PAD clinical DATA study (ethical approval, final study protocol, registry nr) prior to first enrolment.RETRO-VASCULAID-PAD clinical DATA study: retrospective data collection of 6000 patients at clinical partners (Annex Clinical Studies).
Standardised set of parameters to evaluate data outcome measurements
(odnośnik otworzy się w nowym oknie)
Standardised set of parameters defined to evaluate the data outcome measurements.
Project management handbook, month 1
(odnośnik otworzy się w nowym oknie)
Periodic reports with templates (no deliverable) as instructed by the PO.
Submission package PRO-VASCULAID-PAD clinical DATA study
(odnośnik otworzy się w nowym oknie)
Submission package PRO-VASCULAID-PAD clinical DATA study (ethical approval, final study protocol, registry nr, national authorities) prior to first enrolment.PRO-VASCULAID-PAD clinical DATA study: prospective data collection of 420 patients (phase I) at clinical partners (Annex Clinical Studies).